Effects of CPAP on Cardiovascular Risk in Obstructive Sleep Apnea (OSA) and Metabolic Syndrome

NCT00635674 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Obstructive Sleep Apnea
Metabolic Syndrome

Interventions

DEVICE: CPAP device - REMstar Plus, Respironics, Murrysville, USA

Sponsor

Pavol Jozef Safarik University